NCMM Strategy and Vision

Our overall vision is to improve our molecular understanding of health and disease to facilitate improved medical practice.

Photo of pipette in lab at NCMM

Research at NCMM. 

Photo: Trond Isaksen

Current research at NCMM fits the overall heading of Regulatory Biology and Cell Signalling in Health and Disease.

More specifically, we investigate signalling:

  • Across lipid bilayers and into the cell 
  • Orchestrating cell division and differentiation
  • Affecting nuclear receptors and gene expression
  • Mediated by biophysical properties of biological molecules

Approaches and model systems we use are:

  • Bioinformatics
  • Cell biology, neurobiology, immunology, and stem cells
  • Structural biology
  • Synthetic chemistry and chemical biology
  • Yeast and zebra fish model systems.

Research in a wider context

NCMM focuses on a systems medicine approach; implementing the Centre’s research findings into medical concepts, research and practice.

Researchers at NCMM have access to state-of-the art drug screening instruments. Furthermore, to support our translational research, we actively collaborate with local hospitals and with the research environment nationally and internationally, translating our knowledge from bench to bedside. Findings from our research have the promise of improving, in long or short term, diagnostics and treatment of:

  • Cancer
    • Hematopoetic cancers
    • Hormon-regulated cancers (breast, prostate, gynaecological)
    • Oncoimmunology: perturbing tumour immune evasion mechanisms
  • Neurological diseases
  • Cardiovascular diseases
  • Immunological diseases and infection.

National responsibility

NCMM has adopted EMBL’s model for recruitment and organization and operates according to the principles that apply for EMBL.

Furthermore, NCMM has established strong collaborative links to key scientists and research groups working across Norway to further develop its scientific and technological capabilities, and to facilitate translational networking. Our network of Associate Investigators (AIs) and Young Associate Investigators (YAIs) connects NCMM to research in diverse areas of disease and health such as pathology, endocrinology, haematology, autophagy, immunotherapy, infection biology, regenerative medicine, systems pharmacology and hepatology.

Ethical and social responsibility

At NCMM, we are committed to maintaining high ethical standards. We are dedicated to:

  • Responsible Research and Innovation (RRI)
  • Ensuring that the research we carry out is balanced
  • Disseminating our research, and engaging with our local community
  • Equality and diversity.


Published June 1, 2017 9:01 AM - Last modified June 1, 2017 11:37 AM